World’s Top 50 Innovators 2021

Information

Codex and Swinburne join forces to host the World’s Top 50 Innovators 2021.

A distinguished line up of scientists, engineers, entrepreneurs and visionaries who are moving the world forward with the power of their technologies and ideas will convene to share their excitement with you.

Nominate a world-class innovator

An independant panel will pick the top 50 innovators.

The format will be a series of Codex Talks, each of which is a concise presentation, lasting 15 minutes (or less), in which the speaker addresses a challenging question faced by their technology or industry today, and ends with a bold prediction for the future.

The pace of change is accelerating and what was once science fiction is becoming reality. How will you respond to this, when your business could be endangered if you miss a disruptive technology that’s on the horizon today?

Come and join us to learn what’s on the horizon, understand the bigger picture, and future proof your business. Entrepreneurs and innovators from all the industries of the future will be there to fire your imagination..!

Play video

State Library of Victoria, Swanston Street, Melbourne VIC, Australia

14 October 2021 - 16 October 2021

8:00 am - 6:30 pm

Speakers

Dr. Albert Bourla
Chairman and CEO, Pfizer

As Chairman and Chief Executive Officer, Albert Bourla leads Pfizer in its purpose: Breakthroughs that change patients’ lives, with a focus on driving the scientific and commercial innovation needed to have a transformational impact on human health.

During his more than 25 years at Pfizer, Albert has built a diverse and successful career, holding a number of senior global positions across a range of markets and disciplines. Prior to taking the reins as CEO in January 2019, Albert served as the Pfizer’s Chief Operating Officer (COO) beginning in January 2018, responsible for overseeing the Company’s commercial strategy, manufacturing, and global product development functions.

Previously, from February 2016 to December 2017, Albert served as Group President of
Pfizer Innovative Health, which comprised the Consumer Healthcare, Inflammation & Immunology, Internal Medicine, Oncology, Rare Disease and Vaccines business groups. In addition, he created the Patient and Health Impact Group, dedicated to developing solutions for increasing patient access, demonstrating the value of Pfizer’s medicines, and ensuring broader business model innovation.

From January 2014 to January 2016, Albert served as Group President of Pfizer’s Global Vaccines, Oncology, and Consumer Healthcare business, where he was instrumental in building a strong and competitive position in Oncology and expanding the Company’s leadership in Vaccines.

Albert was President and General Manager of Pfizer’s Established Products business from 2010- 2013, leading the development and implementation of strategies and tactics related to Pfizer’s off- patent portfolio, (including legacy brands and generics.

He began his Pfizer career in 1993 in the Animal Health Division as Technical Director of Greece. He held positions of increasing responsibility within Animal Health across Europe, before moving to Pfizer’s New York Global Headquarters in 2001. From there, Albert went on to assume a succession of leadership roles within the Animal Health Division, including US Group Marketing Director (2001- 2004), Vice President of Business Development and New Products Marketing (2004-2006), and Area President of Animal Health Europe, Africa and the Middle East (2006-2009). In 2009, he assumed additional responsibilities for the Asia and Pacific regions.

Albert is a Doctor of Veterinary Medicine and holds a Ph.D. in the Biotechnology of Reproduction from the Veterinary School of Aristotle University. In 2020, he was ranked as America’s top CEO in the Pharmaceuticals sector by Institutional Investor magazine. He is on the executive committee of The Partnership for New York City, a vice president of the International Federation of Pharmaceutical Manufacturers & Associations, a director on multiple boards – Pfizer, Inc., The Pfizer Foundation, PhRMA, and Catalyst – and a Trustee of the United States Council for International Business. In addition, Albert is a member of the Business Roundtable and the Business Council.
Bjarke Ingels
Architect, BIG Group

Bjarke Ingels founded BIG – Bjarke Ingels Group in 2005 after co-founding PLOT Architects in 2001 and working at OMA in Rotterdam. Bjarke defines architecture as the art and science of making sure our cities and buildings fit with the way we want to live our lives. Through careful analysis of various parameters from local culture and climate, ever-changing patterns of contemporary life, to the ebbs and flows of the global economy, Bjarke believes in the idea of information-driven-design as the driving force for his design process. Named one of the 100 Most Influential People in the World by TIME Magazine in 2016, Bjarke has designed and completed award-winning buildings globally.

Bjarke was appointed Knight of the French Order Arts et Lettres and the Knight’s Cross of the Order of Dannebrog in 2019 and 2018, respectively. He was named an Honorary Fellow by the AIA in 2020, the RIBA in 2015 and the RAIC in 2014. The Wall Street Journal recognized Bjarke as Innovator of the Year in 2011, the same year he received the Danish Crown Prince’s Culture Prize. Bjarke was also awarded the Golden Lion at the Venice Biennale in 2004 and the ULI Award for Excellence in 2009. Alongside his architectural practice, Bjarke has taught at Harvard University, Yale University, Columbia University, and Rice University and is an honorary professor at the Royal Academy of Arts, School of Architecture in Copenhagen. He is a frequent public speaker and continues to hold lectures in venues such as TED, WIRED, AMCHAM, 10 Downing Street, the World Economic Forum and many more.
Gregory Colbert
Filmmaker

Photographer/filmmaker Gregory Colbert is the creator of the exhibition Ashes and Snow, an immersive experience of nature that combines photographic artworks, films, and soundscapes, housed in a purpose-built traveling structure called the Nomadic Museum. To date, Ashes and Snow has attracted over 10 million visitors, making it the most attended exhibition by any living artist in history.

Colbert was born in Toronto, Canada, in 1960. He began his career in Paris in 1983 making documentary films on social issues. His first exhibition, Timewaves, opened to wide critical acclaim in 1992 at the Museum of Elysée in Switzerland. For the next ten years, Colbert went off the grid and did not publicly share his art or show any films. He began traveling the world to photograph and film wondrous interactions between animals and humans.

After ten years passed, Colbert returned to present Ashes and Snow at the Arsenale in Venice, Italy, in 2002. With his debut, Photo magazine declared, “A new master is born.” The New York Times, in an article by Alan Riding, stated, “The power of the images comes less from their formal beauty than from the way they envelop the viewer in their mood. . . .They are simply windows to a world in which silence and patience govern time.” Ashes and Snow has been described as “extraordinary” by the Economist, and “distinctive . . . monumental in every sense” by the Wall Street Journal. Stern magazine described the photographs as “fascinating,” and Vanity Fair named Gregory Colbert in its “Best of the Best.”

Speakers

Dr. Albert Bourla
Chairman and CEO, Pfizer

As Chairman and Chief Executive Officer, Albert Bourla leads Pfizer in its purpose: Breakthroughs that change patients’ lives, with a focus on driving the scientific and commercial innovation needed to have a transformational impact on human health.

During his more than 25 years at Pfizer, Albert has built a diverse and successful career, holding a number of senior global positions across a range of markets and disciplines. Prior to taking the reins as CEO in January 2019, Albert served as the Pfizer’s Chief Operating Officer (COO) beginning in January 2018, responsible for overseeing the Company’s commercial strategy, manufacturing, and global product development functions.

Previously, from February 2016 to December 2017, Albert served as Group President of Pfizer Innovative Health, which comprised the Consumer Healthcare, Inflammation & Immunology, Internal Medicine, Oncology, Rare Disease and Vaccines business groups. In addition, he created the Patient and Health Impact Group, dedicated to developing solutions for increasing patient access, demonstrating the value of Pfizer’s medicines, and ensuring broader business model innovation.

From January 2014 to January 2016, Albert served as Group President of Pfizer’s Global Vaccines, Oncology, and Consumer Healthcare business, where he was instrumental in building a strong and competitive position in Oncology and expanding the Company’s leadership in Vaccines.

Albert was President and General Manager of Pfizer’s Established Products business from 2010- 2013, leading the development and implementation of strategies and tactics related to Pfizer’s off- patent portfolio, (including legacy brands and generics.

He began his Pfizer career in 1993 in the Animal Health Division as Technical Director of Greece. He held positions of increasing responsibility within Animal Health across Europe, before moving to Pfizer’s New York Global Headquarters in 2001. From there, Albert went on to assume a succession of leadership roles within the Animal Health Division, including US Group Marketing Director (2001- 2004), Vice President of Business Development and New Products Marketing (2004-2006), and Area President of Animal Health Europe, Africa and the Middle East (2006-2009). In 2009, he assumed additional responsibilities for the Asia and Pacific regions.

Albert is a Doctor of Veterinary Medicine and holds a Ph.D. in the Biotechnology of Reproduction from the Veterinary School of Aristotle University. In 2020, he was ranked as America’s top CEO in the Pharmaceuticals sector by Institutional Investor magazine. He is on the executive committee of The Partnership for New York City, a vice president of the International Federation of Pharmaceutical Manufacturers & Associations, a director on multiple boards – Pfizer, Inc., The Pfizer Foundation, PhRMA, and Catalyst – and a Trustee of the United States Council for International Business. In addition, Albert is a member of the Business Roundtable and the Business Council.

Speakers

Bjarke Ingels
Architect, BIG Group

Bjarke Ingels founded BIG – Bjarke Ingels Group in 2005 after co-founding PLOT Architects in 2001 and working at OMA in Rotterdam. Bjarke defines architecture as the art and science of making sure our cities and buildings fit with the way we want to live our lives. Through careful analysis of various parameters from local culture and climate, ever-changing patterns of contemporary life, to the ebbs and flows of the global economy, Bjarke believes in the idea of information-driven-design as the driving force for his design process. Named one of the 100 Most Influential People in the World by TIME Magazine in 2016, Bjarke has designed and completed award-winning buildings globally.

Bjarke was appointed Knight of the French Order Arts et Lettres and the Knight’s Cross of the Order of Dannebrog in 2019 and 2018, respectively. He was named an Honorary Fellow by the AIA in 2020, the RIBA in 2015 and the RAIC in 2014. The Wall Street Journal recognized Bjarke as Innovator of the Year in 2011, the same year he received the Danish Crown Prince’s Culture Prize. Bjarke was also awarded the Golden Lion at the Venice Biennale in 2004 and the ULI Award for Excellence in 2009. Alongside his architectural practice, Bjarke has taught at Harvard University, Yale University, Columbia University, and Rice University and is an honorary professor at the Royal Academy of Arts, School of Architecture in Copenhagen. He is a frequent public speaker and continues to hold lectures in venues such as TED, WIRED, AMCHAM, 10 Downing Street, the World Economic Forum and many more.
Gregory Colbert
Filmmaker

Photographer/filmmaker Gregory Colbert is the creator of the exhibition Ashes and Snow, an immersive experience of nature that combines photographic artworks, films, and soundscapes, housed in a purpose-built traveling structure called the Nomadic Museum. To date, Ashes and Snow has attracted over 10 million visitors, making it the most attended exhibition by any living artist in history.

Colbert was born in Toronto, Canada, in 1960. He began his career in Paris in 1983 making documentary films on social issues. His first exhibition, Timewaves, opened to wide critical acclaim in 1992 at the Museum of Elysée in Switzerland. For the next ten years, Colbert went off the grid and did not publicly share his art or show any films. He began traveling the world to photograph and film wondrous interactions between animals and humans.

After ten years passed, Colbert returned to present Ashes and Snow at the Arsenale in Venice, Italy, in 2002. With his debut, Photo magazine declared, “A new master is born.” The New York Times, in an article by Alan Riding, stated, “The power of the images comes less from their formal beauty than from the way they envelop the viewer in their mood. . . .They are simply windows to a world in which silence and patience govern time.” Ashes and Snow has been described as “extraordinary” by the Economist, and “distinctive . . . monumental in every sense” by the Wall Street Journal. Stern magazine described the photographs as “fascinating,” and Vanity Fair named Gregory Colbert in its “Best of the Best.”

World’s Top 50 Innovators 2021

Information

TIME

PRICE

Schedule

Speakers

PRICE

Schedule

Speakers

PRICE

Schedule

Speakers

Sponsors